Higher serum Lipoprotein(a) (Lp(a)) concentrations in chronic coronary artery disease are determined by apolipoprotein(a) (apo(a)) genotype and not coronary artery disease (CAD) phenotype.

被引：0
|
作者：
Piper, K [1 ]
Curtis, A [1 ]
Yallop, J [1 ]
Donnelly, T [1 ]
Barker, J [1 ]
Adams, PC [1 ]
Farrer, M [1 ]
机构：
[1] No Reg Genet Serv, Dept Mol Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 61卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1205
引用
收藏
页码：A208 / A208
页数：1
相关论文
共 50 条
  • [11] USE OF LIPOPROTEIN (A) [LP(A)] IN THE ASSESSMENT OF CORONARY-ARTERY DISEASE
    WARTY, V
    MCKAVENEY, T
    DUKES, C
    BUSCH, R
    CHAO, J
    SARITELLI, A
    HERBERT, P
    CLINICAL CHEMISTRY, 1990, 36 (06) : 951 - 951
  • [12] PREVALENCE OF LIPOPROTEIN (A) [LP(A)] EXCESS IN CORONARY-ARTERY DISEASE
    GENEST, J
    JENNER, JL
    MCNAMARA, JR
    ORDOVAS, JM
    SILBERMAN, SR
    WILSON, PWF
    SCHAEFER, EJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (13): : 1039 - 1045
  • [13] Coronary Artery Disease (CAD) and Chronic Kidney Disease (CKD)
    Hirata, Yasunobu
    Kiyosue, Arihiro
    Sahara, Makoto
    Nagai, Ryozo
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : S140 - S140
  • [14] Association of apolipoprotein(A) polymorphism with lipoprotein(A) concentration in coronary artery disease
    Bogavac-Stanojevic, N.
    Jelic-Ivanovic, Z.
    Spasojevic-Kalimanovska, V.
    Topic, A.
    Spasic, S.
    Kalimanovska-Ostric, D.
    Zeljkovic, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 139 - 140
  • [15] No association between apolipoprotein E genotype and coronary artery disease (CAD) or cognitive dysfunction in SLE
    Bruce, IN
    Orlacchio, A
    Gladman, DD
    Urowitz, MB
    Song, YQ
    St George-Hyslop, P
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S285 - S285
  • [16] Serum lipoprotein (a) level and severity of coronary artery disease
    Batalla, A
    Braga, S
    Reguero, JR
    Cubero, GI
    HEART AND VESSELS, 2002, 16 (05) : 214 - 214
  • [17] Serum lipoprotein (a) level and severity of coronary artery disease
    A. Batalla
    Socorro Braga
    Julián R. Reguero
    Gustavo I. Cubero
    Heart and Vessels, 2002, 16 : 214 - 214
  • [18] Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity
    Leistner, David M.
    Laguna-Fernandez, Andres
    Haghikia, Arash
    Abdelwahed, Youssef S.
    Schatz, Anne-Sophie
    Erbay, Aslihan
    Roehle, Robert
    Fonseca, Ana F.
    Ferber, Philippe
    Landmesser, Ulf
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (07) : 856 - 865
  • [19] Serum Osteopontin Concentrations in Relation to Coronary Artery Disease
    Moharnadpour, Anfir Hooshang
    Abdolrahmani, Leila
    Mirzaei, Harried
    Sahebkar, Amirhosein
    Moohebati, Mohsen
    Ghorbani, Maryam
    Ferns, Gordon A.
    Ghayour-Mobarhan, Majid
    ARCHIVES OF MEDICAL RESEARCH, 2015, 46 (02) : 112 - 117
  • [20] Lipoprotein (a) [Lp (a)] and apolipoprotein B [ApoB] as determinants of premature coronary artery disease (CAD) in Iranian patients (age<50).
    Haidari, H
    Sadeghi, B
    Moghadam, M
    CLINICAL CHEMISTRY, 2000, 46 (06) : A94 - A94
12345